Discovering a New Cancer Killer

Dr. Marek Los (2004 Research Grant) 

Marek Los’ research story is classic. While studying the process of cell death he stumbled upon a protein called apoptin which kills cancer cells while sparing healthy cells. Apoptin is sneaky. Cancer cells use certain pathways to keep themselves alive. Apoptin hijacks these pathways and redirects them to kill cancer cells. Even better, apoptin seems to work especially well in hormone refractory prostate cancer – a stage of cancer that is nearly impossible to treat. More research is needed but Los’ work may lead to new treatment options.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive